vasoactive-intestinal-peptide and Diabetic-Nephropathies

vasoactive-intestinal-peptide has been researched along with Diabetic-Nephropathies* in 1 studies

Other Studies

1 other study(ies) available for vasoactive-intestinal-peptide and Diabetic-Nephropathies

ArticleYear
Diabetic neuropathy: an evaluation of the use of quercetin in the cecum of rats.
    World journal of gastroenterology, 2013, Oct-14, Volume: 19, Issue:38

    To investigate the effect of quercetin supplementation on the myenteric neurons and glia in the cecum of diabetic rats.. Total preparations of the muscular tunic were prepared from the ceca of twenty-four rats divided into the following groups: control (C), control supplemented with quercetin (200 mg/kg quercetin body weight) (CQ), diabetic (D) and diabetic supplemented with quercetin (DQ). Immunohistochemical double staining technique was performed with HuC/D (general population)/nitric oxide synthase (nNOS), HuC-D/S-100 and VIP. Density analysis of the general neuronal population HuC/D-IR, the nNOS-IR (nitrergic subpopulation) and the enteric glial cells (S-100) was performed, and the morphometry and the reduction in varicosity population (VIP-IR) in these populations were analyzed.. Diabetes promoted a significant reduction (25%) in the neuronal density of the HuC/D-IR (general population) and the nNOS-IR (nitrergic subpopulation) compared with the C group. Diabetes also significantly increased the areas of neurons, glial cells and VIP-IR varicosities. Supplementation with quercetin in the DQ group prevented neuronal loss in the general population and increased its area (P < 0.001) and the area of nitrergic subpopulation (P < 0.001), when compared to C group. Quercetin induced a VIP-IR and glial cells areas (P < 0.001) in DQ group when compared to C, CQ and D groups.. In diabetes, quercetin exhibited a neuroprotective effect by maintaining the density of the general neuronal population but did not affect the density of the nNOS subpopulation.

    Topics: Animals; Cecum; Diabetes Mellitus, Experimental; Diabetic Nephropathies; ELAV Proteins; ELAV-Like Protein 3; ELAV-Like Protein 4; Male; Myenteric Plexus; Neuroglia; Neurons; Neuroprotective Agents; Nitrergic Neurons; Nitric Oxide Synthase Type I; Quercetin; Rats; Rats, Wistar; S100 Proteins; Vasoactive Intestinal Peptide

2013